(Q43021553)

English

Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model

scientific article published in January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

methicillin-resistant Staphylococcus aureus

0 references

hospitalization

1 reference

based on heuristic

inferred from title

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

object named as

Jack Brown

1

0 references

author name string

Joseph A Paladino

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

567-575

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

https://scigraph.springernature.com/pub.10.2165/11533020-000000000-00000

0 references

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Evaluation and review of pharmacoeconomic models

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients

1 reference

https://api.crossref.org/works/10.2165%2F11533020-000000000-00000

21 January 2018

Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20550222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retrospective evaluation of therapies for Staphylococcus aureus endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20550222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit

1 reference

https://pubmed.ncbi.nlm.nih.gov/20550222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20550222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11533020-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43021553&oldid=1977539230"